Race and Heart Disease in America Series. A three-part series in partnership with the Association of Black Cardiologists (ABC) Medical Alley Association (MAA) and the Preventive Cardiovascular Nurses Association (PCNA).…
Race and Heart Disease in America Series. A three-part series in partnership with the Association of Black Cardiologists (ABC) Medical Alley Association (MAA) and the Preventive Cardiovascular Nurses Association (PCNA).…
The monoclonal antibody combinations bamlanivimab/etesevimab and casirivimab/imdevimab (REGEN-COV) should only be used for COVID-19 patients exposed to variants other than Omicron, the FDA said on Monday. The agency revised the…
Regeneron continues to progress next generation antibodies that retain potency against Omicron, Delta and other variants of concern The U.S. Food and Drug Administration (FDA) today amended the Emergency Use…
WILMINGTON, Del., January 24, 2022 – Eplontersen has been granted Orphan Drug Designation (ODD) in the US by the Food and Drug Administration (FDA) for the treatment of transthyretin-mediated amyloidosis,…
Evkeeza is a first-in-class medicine approved by the U.S. Food and Drug Administration (FDA) and European Commission (EC) to treat an ultra-rare inherited form of high cholesterol TARRYTOWN, N.Y. and…
